# PET-Based Imaging of Radiolabeled CIT-013

> **NCT07147959** · PHASE2 · RECRUITING · sponsor: **Citryll BV** · enrollment: 12 (estimated)

## Conditions studied

- RA

## Interventions

- **DRUG:** [89Zr]Zr-CIT

## Key facts

- **NCT ID:** NCT07147959
- **Lead sponsor:** Citryll BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07147959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07147959, "PET-Based Imaging of Radiolabeled CIT-013". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07147959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*